Gland Pharma Cash Flow Annual

Trade
BSE: 543245 | NSE: GLAND | ISIN: INE068V01023 | Sector: Biotechnology & Drugs
1,785.00 +28.45 (1.62%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 1,132.541,054.581,618.551,334.81
Depreciation/ Depletion 344.57146.74110.3098.78
Non- Cash Items -120.96-108.54-138.49-81.48
Changesin Working Capital -359.35-728.81-799.59-747.18
Cashfrom Operating Activities 996.80363.97790.77604.93
Capital Expenditures -398.26-223.12-522.12-228.78
Other Investing Cash Flow Items Total -1,358.661,431.31-480.50-1,295.22
Cashfrom Investing Activities -1,756.911,208.19-1,002.62-1,524.00
Financing Cash Flow Items -25.61-6.29-3.40-2.33
Issuance( Retirement)of Stock Net 0.5321.5038.551,241.81
Issuance( Retirement)of Debt Net -774.33-0.29-0.25-1.02
Cashfrom Financing Activities -799.4214.9234.901,238.46
Foreign Exchange Effects 7.723.003.313.58
Net Changein Cash -1,551.811,590.08-173.64322.97
Cash Interest Paid 25.616.293.402.33
Cash Taxes Paid 306.15310.87406.51311.43
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts